Drugs / Samelisant
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase not stated1 trial | ||||||
| — | NCT05530447 | — | narcolepsy | Suven Life Sciences Limited | No longer available | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT07540364 Comparator | Jun 2026 → Nov 2027 expected | narcolepsy | Suven Life Sciences Limited | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Samelisant | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07540364 ↗ |